Description
"Intelligent Medicine Radio: Part 2: Wound Healing" features Ronald Hoffman (MD) discussing strategies to improve healing in individuals with poor circulation or diabetes. He explains how nitric oxide supplements, arginine, citrulline, and vitamin C support blood flow and tissue repair while emphasizing the role of blood sugar control in recovery. Dr. Hoffman also recommends hyperbaric oxygen therapy and highlights the benefits of specific supplement regimens—including NTFactor—for energy, cell repair, and better wound healing outcomes.
Intelligent Medicine Radio: Part 2 – Wound Healing
Guest
This time, there are no guests—just Ronald Hoffman delving deeply into today's topic.
Category
Pain Management, Supplements, Blood Health
About The Host
Ronald Hoffman (MD) is an integrative medicine physician and certified nutrition specialist with decades of clinical experience. He founded the Hoffman Center in New York City and has been a leader in blending conventional care with evidence-based alternative therapies. He is the author of "Intelligent Medicine" and "How to Talk with Your Doctor," which provide practical guidance for improving health through informed, collaborative decision-making.
Ronald Hoffman (MD) is an integrative medicine physician and certified nutrition specialist with decades of clinical experience. He founded the Hoffman Center in New York City and has been a leader in blending conventional care with evidence-based alternative therapies. He is the author of "Intelligent Medicine" and "How to Talk with Your Doctor," which provide practical guidance for improving health through informed, collaborative decision-making.
About The Guest
This episode features Ronald Hoffman as the sole presenter, offering his expertise and insights.
This episode features Ronald Hoffman as the sole presenter, offering his expertise and insights.
Support the Guest
This episode does not include any guest appearances, or information about the guests' website, Instagram, Facebook, or Twitter profiles is currently unknown to us. We’ll update this page as soon as more details become available.
